7 unchanged sentences
Certificate of Amendment to Restated Certificate of Incorporation of the Registrant
−Removed: Filed herewith
Amended and Restated Bylaws of the Registrant
22 unchanged sentences
Stock Option and Incentive Plan as amended
−Removed: Collaboration and License Agreement by and between Registrant and Kyorin Pharmaceutical Co., Ltd., dated January 6, 2020
−Removed: February 3, 2020
Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
2 unchanged sentences
Filed herewith
−Removed: Incorporated by Reference
−Removed: Exhibit Title
Certification of Principal Executive Officer pursuant to 18 U.S.C.
4 unchanged sentences
Filed herewith
+Added: Incorporated by Reference
+Added: Exhibit Title
XBRL Instance Document
11 unchanged sentences
Indicates a management contract or compensatory plan, contract or arrangement.
−Removed: Certain portions have been omitted because the Registrant has determined that the information is not material and would likely cause competitive harm to the Registrant if publicly disclosed.
The information in Exhibits 32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report on Form 10-Q), unless the Registrant specifically incorporates the foregoing information into those documents by reference.
1 unchanged sentence
aTyr Pharma, Inc.
+Added: August 13, 2020
/s/ Sanjay S.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.